Financial Data and Key Metrics Changes - For Q4 2025, revenue was $61.2 million, representing a 7.5% year-over-year growth [14] - Full year revenue totaled $244.5 million, reflecting a 6.4% growth year-over-year [14] - Adjusted EBITDA for the full year is expected to range from $21 million to $23 million, or 8.3% to 8.9% of revenue [21] Business Line Data and Key Metrics Changes - General practice revenue grew 6.2% to $44.7 million in Q4 2025 [14] - Multi-specialty practice revenue grew 11.3% to $16.5 million in Q4 2025 [14] - Specialty practice revenue for the full year grew 11% to $65.5 million [15] Market Data and Key Metrics Changes - The U.S. dental service market is estimated to be $173 billion, growing at approximately 4%-5% annually [7] - There are an estimated 200,000 licensed dentists in the U.S., with over two-thirds being solo practitioners or small independent groups [7] Company Strategy and Development Direction - The company aims to increase the number of doctors serving patients through adding doctors to existing practices, acquiring additional practices, and opening new practices [6] - The approach to M&A is disciplined, focusing on cultural fit and long-term value creation [8] - The company plans to enter 2-3 new markets over the next few years with a land and expand strategy [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to deliver consistent organic growth while pursuing a disciplined M&A strategy [14] - Patient retention remains high at 89.9%, indicating strong relationships between affiliated doctors and their patients [9] - The company expects full year 2026 revenue to range from $254 million to $258 million, with same-practice revenue growth of 3.5%-5% [21] Other Important Information - The company launched an Employee Stock Purchase Plan to allow doctors and team members to share in the value created [3] - Significant investments were made in technology and employee development, including the implementation of an AI tool for radiograph reading [10] Q&A Session Summary Question: Can you talk about the robust pipeline and how it compares to 6-12 months ago? - Management noted good momentum coming into the year with several closings and expressed excitement about expanding in Arizona [25] Question: How significant is the team working on M&A opportunities? - The M&A effort is led by Jason Halupnick, supported by an analyst, with overall leadership deeply involved [26] Question: How long does the sales cycle for acquisitions typically take? - The sales cycle varies, with smaller transactions taking a couple of months and larger ones potentially taking years to develop relationships [27] Question: How do you implement efficiency programs in acquired practices? - Implementation timelines vary, with some practices achieving efficiency in three months, while others may take 12 to 18 months to reach multi-doctor status [33] Question: Will the software platforms be sold independently? - Currently, the company is focused on internal deployment of technology and does not plan to sell it externally [37]

Financial Data and Key Metrics Changes - The company held its Annual Meeting of Stockholders on June 5, 2025, but specific financial data and key metrics were not disclosed during the meeting [1][2][3] Business Line Data and Key Metrics Changes - No specific data or key metrics related to individual business lines were provided in the meeting [1][2][3] Market Data and Key Metrics Changes - There was no mention of market data or key metrics changes during the meeting [1][2][3] Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and approval of various proposals, indicating a commitment to governance and strategic planning, but specific strategic directions or competitive insights were not discussed [1][2][3][8][9] Management's Comments on Operating Environment and Future Outlook - Management did not provide comments on the operating environment or future outlook during the meeting [1][2][3] Other Important Information - The company proposed amendments to its equity incentive plan and employee stock purchase plan, reflecting ongoing efforts to align compensation with shareholder interests [10][11][27][32] Q&A Session All Questions and Answers Question: What were the results of the proposals voted on? - Proposal one: Election of directors was approved [14][30] - Proposal two: Advisory vote on executive compensation was approved [14][31] - Proposal three: Amendment to the equity incentive plan was approved [14][32] - Proposal four: Amendment to the employee stock purchase plan was approved [14][32] - Proposal five: Selection of KPMG as the independent auditor for 2025 was ratified [14][32]

Group 1 - CNO Financial Group, Inc. provides life and health insurance, annuities, financial services, and workforce benefits solutions, focusing on middle-income America [1] - The company manages 3.2 million policies and has total assets amounting to $37.4 billion [1] - CNO employs 3,400 associates, 4,800 exclusive agents, and over 5,500 independent partner agents to assist customers with financial decisions [1] Group 2 - At the annual meeting, nine directors were elected to serve a one-year term [2] - The executive compensation for named executive officers was approved by a non-binding advisory vote [2] - PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2025 [2] - The company approved an Amended and Restated Certificate of Incorporation to include a Replacement NOL Protective Amendment [2] - An Amended and Restated Long-Term Incentive Plan was approved [2] - An Amended and Restated Employee Stock Purchase Plan was also approved [2]